Gail Frances McIntyre, Senior Vice President-Research at Furiex Pharmaceuticals, Inc. (FURX), sold 74,457 shares at $105.00 ($7.8M) on 2014-06-16, disclosed to the SEC on 2014-06-18.
Open-market sale of $7.8M FURX by Senior Vice President-Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.00 | 3,804 | $399K | 5.1% |
| 2 | $105.00 | 32,928 | $3.5M | 44.2% |
| 3 | $105.01 | 26,000 | $2.7M | 34.9% |
| 4 | $105.05 | 3,717 | $390K | 5.0% |
| 5 | $105.00 | 8,008 | $841K | 10.8% |
| Total | $105.01 avg | 74,457 |
| $7.8M |
| 100% |
| Filing → |
| FURX | SELL | 2014-06-12 | $183K | — | Filing → |
| FURX | SELL | 2013-09-18 | $800K | — | Filing → |
| FURX | SELL | 2013-07-23 | $423K | — | Filing → |